#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Christine Dieterich Email
Director CMC and Preclinical . InDex Pharmaceuticals AB
Solna,
Locationc******************@indexpharma.com
Primary EmailHow to contact Christine Dieterich
Join and see Christine's contact info for free!Current Roles
Employees:
27Revenue:
$5.4MAbout
InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company's foremost asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe active ulcerative colitis - a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in treatment of various immunological diseases. InDex is based in Stockholm, Sweden. The company's shares are traded on Nasdaq First North Growth Market Stockholm.InDex Pharmaceuticals AB Address
Berzelius väg 13Solna, null